Dr. Peter Johann is a Managing General Partner of NGN Capital since 2004 and invested successfully in biotech and medical device companies.
Prior to joining NGN he was the Division Head of Corporate Development at Boehringer Ingelheim. His responsibilities included strategic planning, strategic projects, M&A, business development and licensing. He identified and evaluated licensing, M&A and co-promotion deals.
Prior to this Dr. Johann held several positions in marketing, business development, sales and product management at F. Hoffmann-La Roche, Boehringer Mannheim, Kaneka and Röhm.